Phase 2 Metastatic Uveal Melanoma trials recruiting now

All Metastatic Uveal Melanoma trials, every phase

Other phases for Metastatic Uveal Melanoma

Phase 2 Metastatic Uveal Melanoma trials

• A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
  NCT07636785 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
  NCT06581406 · Phase: Phase 2, Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 33 locations
• Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
  NCT07063875 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma
  NCT07627698 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
  NCT07136181 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
  NCT07276386 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
  NCT06121180 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
  NCT03947385 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations
• Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
  NCT06627244 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tebentafusp-tebn With LDT in Metastatic UM
  NCT06626516 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.